The St. Jude Children's Research Hospital Medication-Use Safety & Policy Residency program is a PGY2 training program that provides advanced training in medication safety, with additional exposure in medication-use policy and clinical informatics. The complex and high risk nature of treatment provided at St. Jude provides a unique learning environment for patient safety and quality that can be later applied to any health care setting. The resident will gain experience in medication error and adverse drug event reporting processes, lead medication safety assessments and improvement efforts to prevent future events and reactions, and work to maximize the patient safety benefits of the electronic medical record. Other activities may include newsletter writing, policy and guideline development, newsletter writing, assistance with pharmacy investigational services, and experience with a fully integrated electronic medical record. The resident will participate in Root Cause Analyses, serve on the Medication Use Safety Team, and attend Pharmacy and Therapeutics Committee meetings. Experience in teaching is acquired through providing lectures, in-services, and precepting pharmacy students. An independent project focused on medication safety will be carried out during the course of the residency, with presentation at a regional or national meeting. Experiences during the residency will enable the resident to seek a career focused on medication safety, medication-use policy, or clinical informatics.
The resident will undergo an orientation/training period. The core longitudinal rotations are focused on medication-use safety improvements with emphasis on informatics, medication-use policy, and quality management. A variety of elective rotations, including other organizations, are available.
Requirements include a Doctor of Pharmacy degree, successul completion of a PGY1 residency, license (or eligibility) to practice pharmacy in Tennessee.
About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is a premier basic science research center and one of the largest centers in the world for research and treatment of pediatric cancers and other catastrophic diseases of children. The hospital's mission is to find cures for children with catastrophic illness through research and treatment. The department's mission is to provide the highest quality comprehensive clinical pharmaceutical care to children with catastrophic diseases, always working to integrate research findings into clinical care as quickly as possible. The department consists of professional, technical, and support personnel - all focused on providing care across the inpatient/outpatient continuum. The Pharmaceutical Department includes an accredited clinical laboratory responsible for all clinical drug assays and comprehensive centralized and decentralized distributive and clinical pharmacy services, all supported by a fully integrated state-of-the-art electronic medical record, including CPOE. Departmental faculty and clinical staff are essential members of a laboratory-based clinical care and research program focusing on pediatric clinical therapeutics.